Extensively drug resistant tuberculosis: problem will get worse in South Africa unless poverty is alleviated.
作者信息
Benatar Solomon R
出版信息
BMJ. 2006 Sep 30;333(7570):705. doi: 10.1136/bmj.333.7570.705-a.
Abstract
摘要
相似文献
1
Extensively drug resistant tuberculosis: problem will get worse in South Africa unless poverty is alleviated.广泛耐药结核病：除非减轻贫困，否则南非的这一问题将恶化。
BMJ. 2006 Sep 30;333(7570):705. doi: 10.1136/bmj.333.7570.705-a.
2
The emerging crisis of drug-resistant tuberculosis in South Africa: lessons from New York City.南非耐药结核病新危机：来自纽约市的教训
Clin Infect Dis. 2008 Jun 1;46(11):1729-32. doi: 10.1086/587903.
3
Extensively drug-resistant tuberculosis (XDR-TB) among health care workers in South Africa.南非医疗机构中广泛耐药结核病（XDR-TB）的情况。
Trop Med Int Health. 2010 Oct;15(10):1179-84. doi: 10.1111/j.1365-3156.2010.02590.x.
4
Extensively drug resistant tuberculosis.广泛耐药结核病
BMJ. 2006 Sep 16;333(7568):559-60. doi: 10.1136/bmj.38971.587222.AB.
5
Infectious disease. Extensively drug-resistant TB gets foothold in South Africa.传染病。广泛耐药结核病在南非站稳脚跟。
Science. 2006 Sep 15;313(5793):1554. doi: 10.1126/science.313.5793.1554a.
6
Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.耐多药和广泛耐药结核病：对南非艾滋病毒疫情及抗逆转录病毒治疗推广的影响
J Infect Dis. 2007 Dec 1;196 Suppl 3:S482-90. doi: 10.1086/521121.
7
Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.南非耐多药（MDR）和广泛耐药（XDR）结核病的出现和治疗。
Infect Genet Evol. 2012 Jun;12(4):686-94. doi: 10.1016/j.meegid.2011.07.019. Epub 2011 Aug 4.
8
9
Drug-resistant and extensively drug-resistant tuberculosis in southern Africa.南部非洲的耐多药和广泛耐药结核病。
Curr Opin Pulm Med. 2010 May;16(3):180-5. doi: 10.1097/MCP.0b013e3283378680.
10
[Resistant tuberculosis increasing among HIV-infected in South Africa].[南非艾滋病毒感染者中耐多药结核病病例不断增加]
Tidsskr Nor Laegeforen. 2006 Dec 14;126(24):3322.
引用本文的文献
1
New Conjugates of Quinoxaline as Potent Antitubercular and Antibacterial Agents.作为强效抗结核和抗菌剂的喹喔啉新共轭物。
Int J Med Chem. 2016;2016:6471352. doi: 10.1155/2016/6471352. Epub 2016 Mar 8.
2
Design, synthesis and antitubercular activity of certain nicotinic Acid hydrazides.某些烟酸酰肼的设计、合成及抗结核活性
Molecules. 2015 May 15;20(5):8800-15. doi: 10.3390/molecules20058800.
3
Synthesis, biological evaluation and 2D-QSAR study of halophenyl bis-hydrazones as antimicrobial and antitubercular agents.卤代苯基双腙类化合物作为抗菌和抗结核药物的合成、生物学评价及二维定量构效关系研究
Int J Mol Sci. 2015 Apr 20;16(4):8719-43. doi: 10.3390/ijms16048719.
4
Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.喹喔啉-2-羧酸1,4-二氮氧化物衍生物在实验性结核病中的疗效
Antimicrob Agents Chemother. 2008 Sep;52(9):3321-6. doi: 10.1128/AAC.00379-08. Epub 2008 Jul 14.
5
In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.喹喔啉1,4 - 二氧化物的酮和酰胺衍生物的体外和体内抗分枝杆菌活性
J Antimicrob Chemother. 2008 Sep;62(3):547-54. doi: 10.1093/jac/dkn214. Epub 2008 May 23.
6
XDR-TB in South Africa: no time for denial or complacency.南非的广泛耐药结核病：不容否认或自满
PLoS Med. 2007 Jan;4(1):e50. doi: 10.1371/journal.pmed.0040050.
本文引用的文献
1
Extensively drug resistant tuberculosis.广泛耐药结核病
BMJ. 2006 Sep 16;333(7568):559-60. doi: 10.1136/bmj.38971.587222.AB.
2
Health care reform and the crisis of HIV and AIDS in South Africa.南非的医疗保健改革与艾滋病毒和艾滋病危机。
N Engl J Med. 2004 Jul 1;351(1):81-92. doi: 10.1056/NEJMhpr033471.
3
Prospects for global health: lessons from tuberculosis.全球健康的前景：结核病的教训
Thorax. 1995 May;50(5):487-9. doi: 10.1136/thx.50.5.487.
Zotero 插件